Dotmatics, Compugen sign licensing deal

By The Science Advisory Board staff writers

March 3, 2021 -- Dotmatics has signed a licensing deal that grants Compugen rights to its informatics software.

Under the multiyear agreement, Compugen scientists based at the company's research and development facility in Israel will have access to a single information management platform. The tools enable gathering, analyzing, and visualizing project data.

Compugen will have access to Dotmatics' software as a service (SaaS) technology including bioregister, inventory, studies notebook, and platform applications, which may contribute to identifying novel immuno-oncology drug targets and biomarkers.

Dotmatrics technology will replace Compugen's current laboratory information management system (LIMS) and electronic lab notebook (ELN).

Copyright © 2021
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here